← Leaderboards
John Ravits
Benaroya Research Inst At Virginia Mason
$4,841,926
Attributed
$8,526,841
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2006–25$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,526,841 · 5
By mechanism
R01$4,586,805 · 2
RF1$3,081,936 · 1
R21$858,100 · 2
Top collaborators
- Jeffrey D Esko5 shared
- Christina Sigurdson5 shared
- Bogdan Bintu1 shared
- Don W. Cleveland1 shared
Others in their field
Top investigators on “Neurodegenerative Disorders”
- Adam L Boxer · Mayo Clinic Rochester$61,054,677
- Paul S. Aisen · Cognition Therapeutics, Inc.$56,063,985
- Ronald C Petersen · Mayo Clinic Coll Of Medicine, Rochester$55,774,157
- Reisa A. Sperling · Banner Health$50,784,577
- Jane S Paulsen · University Of Wisconsin-Madison$38,012,377
- John Q. Trojanowski · University Of Pennsylvania$37,152,274
Research focus
Neurodegenerative DisordersNeuronsAlzheimer&AposProteinsAntisense OligonucleotidesMolecularPathologyCellsAffectS DiseaseGenesAmyotrophic Lateral SclerosisPathologicAffinityMotor NeuronsLocationBindingMessenger RnaMouse ModelIn VitroKnock-In MouseAstrocytesGeneticGrant
Grant awards (14)
Mechanism of ALS/FTD determined by multimodal single cell spatial transcriptomics$3,081,936
RF1 · FY2025 · NS
Mechanisms of Prion Aggregation$480,952
R01 · FY2025 · NS
Mechanisms of Prion Aggregation$480,834
R01 · FY2024 · NS
Mechanisms of Prion Aggregation$480,718
R01 · FY2023 · NS
Mechanisms of Prion Aggregation$501,557
R01 · FY2022 · NS
Mechanisms of Prion Aggregation$501,375
R01 · FY2021 · NS
ELAVL3 in ALS/FTD$417,259
R21 · FY2021 · NS · contact PI
Developing ASO Therapy for Repeat Expanded C9orf72 ALS-FTD$428,588
R01 · FY2018 · NS · contact PI
Developing ASO Therapy for Repeat Expanded C9orf72 ALS-FTD$428,588
R01 · FY2017 · NS · contact PI
Developing ASO Therapy for Repeat Expanded C9orf72 ALS-FTD$428,588
R01 · FY2016 · NS · contact PI
Developing ASO Therapy for Repeat Expanded C9orf72 ALS-FTD$428,588
R01 · FY2015 · NS · contact PI
Developing ASO Therapy for Repeat Expanded C9orf72 ALS-FTD$427,017
R01 · FY2014 · NS · contact PI
Microgenomic Studies of ALS$240,816
R21 · FY2007 · NS · contact PI
Microgenomic Studies of ALS$200,025
R21 · FY2006 · NS · contact PI